ArticleiScience2026
Metabolic exhaustion underlies sarcopenic obesity susceptibility in aging mice as revealed by multi-omics factor analysis.
Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sarcopenic obesity (SO) affects up to 40% of older adults with obesity, yet many remain protected despite comparable metabolic burden. The molecular basis for this heterogeneity remains unknown. We exposed 12-month-old female mice to high-fat diet (HFD) or standard diet for 7 months. Multi-omics factor analysis integrated muscle transcriptomics and metabolomics to identify factors explaining phenotypic variation. Despite uniform obesity development, aging HFD mice showed marked heterogeneity in muscle outcomes. Factor 3 uniquely distinguished dietary groups and predicted muscle dysfunction independent of adiposity severity. It revealed metabolic exhaustion: lipid overload-induced upregulation of fatty acid oxidation genes and oxidative markers, long-chain acylcarnitine accumulation, and free L-carnitine depletion, indicating incomplete β-oxidation. Activation of p53, TNF/NFκB, and oxidative stress pathways indicated comprehensive metabolic decompensation. Plasma acetylcarnitine and pantothenol achieved area under curve (AUC) 0.91 for discriminating sarcopenia phenotypes. Individual susceptibility to SO reflects differential metabolic exhaustion rather than obesity severity, detectable through circulating biomarkers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.